Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Little

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|November 1, 2018
Clinically, what ought we to believe?John D Little, Lorraine Davison, Robert D Little
Pediatric Gastroenterology, Hepatology & Nutrition|May 18, 2026
Week 14 Infliximab Level Provides Modest Benefit to Clinical Outcomes in Children with Crohn's DiseaseAsha Jois, Rachel Horn, Anysha Walia, et al.
Journal of Clinical Medicine|July 14, 2023
The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBDKathryn Demase, Cassandra K Monitto, Robert D Little, et al.
Digestive Diseases and Sciences|March 25, 2021
De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 MonthsRobert D Little, Isabel E Chu, Mark G Ward, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2023
Clinical features and outcomes of adult idiopathic megarectumKyle Wu, Robert D Little, Andrew Long, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Alimentary Pharmacology & Therapeutics|May 8, 2020
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's diseaseAshish Srinivasan, Daniel R van Langenberg, Robert D Little, et al.
Scientific Reports|July 26, 2017
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritisRobert D Little, Iván Prieto-Potin, Sandra Pérez-Baos, et al.
Journal of Crohn'S & Colitis|May 28, 2026
The introduction of an intestinal ultrasound service is associated with significantly reduced endoscopy usage in an inflammatory bowel disease service-the SCOPELESS studyGrace S Feng, Robert D Little, Zaid Ardalan, et al.
Journal of Clinical Medicine|October 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous BiologicsRobert D Little, Mark G Ward, Emily Wright, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|November 1, 2018
Clinically, what ought we to believe?John D Little, Lorraine Davison, Robert D Little
Pediatric Gastroenterology, Hepatology & Nutrition|May 18, 2026
Week 14 Infliximab Level Provides Modest Benefit to Clinical Outcomes in Children with Crohn's DiseaseAsha Jois, Rachel Horn, Anysha Walia, et al.
Journal of Clinical Medicine|July 14, 2023
The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBDKathryn Demase, Cassandra K Monitto, Robert D Little, et al.
Digestive Diseases and Sciences|March 25, 2021
De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 MonthsRobert D Little, Isabel E Chu, Mark G Ward, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2023
Clinical features and outcomes of adult idiopathic megarectumKyle Wu, Robert D Little, Andrew Long, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Alimentary Pharmacology & Therapeutics|May 8, 2020
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's diseaseAshish Srinivasan, Daniel R van Langenberg, Robert D Little, et al.
Scientific Reports|July 26, 2017
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritisRobert D Little, Iván Prieto-Potin, Sandra Pérez-Baos, et al.
Journal of Crohn'S & Colitis|May 28, 2026
The introduction of an intestinal ultrasound service is associated with significantly reduced endoscopy usage in an inflammatory bowel disease service-the SCOPELESS studyGrace S Feng, Robert D Little, Zaid Ardalan, et al.
Journal of Clinical Medicine|October 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous BiologicsRobert D Little, Mark G Ward, Emily Wright, et al.
Pageof 2